CD1D and neoplasm: Furthermore, due to the inclusion of the atypical adjuvant αGC, another T cell with anti-tumor properties, namely invariant natural killer T (iNKT) cells, will get activated as a consequence of the presentation of the glycolipid antigen in the context of CD1d complexes by DCs 11.